KYTHERA BIOPHARMACEUTICALS INC
DelistedCIK 1436304fmd_1FAGEZK2QYNDNP1W29A8150GJ4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2015, 19 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| Gross profit | 4 | 12 | 18 | – | – |
| Research and development | 15 | 16 | 43 | 34 | 48 |
| Total operating expenses | 22 | 23 | 54 | 50 | 132 |
| Operating income | (18) | (11) | (36) | (50) | (132) |
| Interest expense | – | 0 | 0 | 2 | 4 |
| Interest and investment income | – | – | – | 0 | 0 |
| Income tax expense | – | – | – | 0 | 0 |
| Net income | (16) | (11) | (37) | (52) | (136) |